Current medical guidelines have prompted implementation of increasing numbers of implantable rhythm devices, be they pacemakers, internal cardioverter–defibrillators or loop recorders. These devices ...
iData Research: Global Cardiac Rhythm Management market to hit $36B by 2032. Leadless pacing and pulsed field ablation lead the industry.
Pune, June 03, 2020 (GLOBE NEWSWIRE) -- Technological advancements in cardiac rhythm devices are driving the global cardiac rhythm management devices market. Fortune Business Insights in a report, ...
CHICAGO (Reuters) - Two studies on implanted cardiac rhythm devices presented at a major medical meeting showed mixed results for patients whose heart conditions are not normally treated with the ...
A heart rhythm specialist explains how electrical signals keep the heart beating—and how wearables are helping detect ...
Background: A relaxation of the prohibition of scanning cardiac rhythm device patients is underway, largely because of the growing experience of safe scanning events at 1.5T. Magnetic resonance ...
DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Rhythm Management Devices Market - Segmented by Product Type and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ...
(Reuters) - AtriCure Inc's Synergy Ablation System heart-rhythm device is safe and effective, but its trial size and design raise some concerns, U.S. medical device reviewers said. The latest trial ...
Johnson & Johnson's halt of U.S. sales of a new heart-rhythm device due to safety concerns is hobbling a major strategic push by the company into one of the industry's fastest-growing markets. The ...
SILVER SPRING, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a national group ...
WAYNE, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of two new devices designed to enhance ...
Johnson & Johnson is relaunching sales of a promising heart-rhythm device after a safety scare, but with a new warning for doctors that analysts say could hamper its market potential. J&J said late ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results